OLIN CALLAGHAN: Open Payments
NPI 1902891930 · DELMAR, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,690 in 138 payments from 23 companies in 2025. Trend: 2023 $2,256 · 2024 $3,395 · 2025 $2,690
Food & beverage: $2,690
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $481 |
| ABBVIE INC. | 22 | $392 |
| GlaxoSmithKline, LLC. | 25 | $309 |
| PFIZER INC. | 22 | $233 |
| Novo Nordisk Inc | 12 | $233 |
| Lilly USA, LLC | 11 | $215 |
| Exact Sciences Corporation | 7 | $143 |
| SANOFI-AVENTIS U.S. LLC | 4 | $113 |
| Phathom Pharmaceuticals, Inc. | 1 | $113 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $73 |
Products named: FARXIGA, NURTEC ODT, SHINGRIX, TRELEGY ELLIPTA, AIRSUPRA, QULIPTA, ELIQUIS, BREZTRI.
Industry payments across NY — which companies pay providers there.
